Dennis Gillings

$2.25B

as of 10/04/24

About Dennis Gillings

Dennis Gillings is the founder and former CEO and chairman of clinical research firm Quintiles Transnational, which changed its name to IQVIA in 2017.

Gillings, a former biostatistics professor, launched Quintiles in 1982 with the goal of making clinical trials for drugs faster and more efficient.

Gillings retired from the board of IQVIA in April 2018. He still serves as a partner of healthcare-focused investment firm NovaQuest Capital.

In November 2019, NovaQuest raised $275 million for its first private equity fund. The firm manages about $2.75 billion in assets.

Quintiles reached annual revenues of $5.7 billion before merging with healthcare data firm IMS Health in 2016.

Personal stats

Citizenship

United Kingdom

Source of wealth

Clinical trials

Residence

Durham, North Carolina

Birth date

04/25/44 (age 80)

Self-made

self-made

Dennis Gillings’s fortune is worth

37K

troy ounces of gold

35K

median U.S. household

22K

median U.S. income

0.045%

U.S. credit card volume

0.009%

GDP of the United States

0.007%

United States debt

Net worth history

Annual ranking

Did you know?

Gillings received a Commander of the Order of the British Empire from Queen Elizabeth in 2004 for his work in the pharmaceutical industry.